SR

Srinivas Rayala

Active Director Director DIN 11538147
DIN 11538147 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivas Rayala

Data last updated:

Srinivas Rayala is a Director at Rook Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11538147
Primary Designation Director
Industry Pharma
First Appointment 11 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rook Pharmaceuticals Private Limited U21001TS2026PTC211096
Director11 Feb 20262026Active

Board colleagues of Srinivas Rayala

Directorship timeline

Open interactive timeline →
Rook Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srinivas Rayala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Rayala

Srinivas Rayala currently holds 1 directorship: Rook Pharmaceuticals Private Limited (Director, since 11 Feb 2026).

Srinivas Rayala was first appointed on 11 Feb 2026 as Director at Rook Pharmaceuticals Private Limited.

The current boards of Srinivas Rayala's companies include Manikanta Surya Pradeep Kruthiventi (Rook Pharmaceuticals Private Limited), Ramabhadram Gadi (Rook Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available